Back to search

Article

Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus

2022-11-01

Abstract excerpt

<title>Abstract</title> <p><bold>background/purpose: </bold>The prognosis of hepatocellular carcinoma (HCC) patients with<bold> </bold>portal vein tumor thrombus (PVTT) is generally poor and hepatectomy is optional for these patients. This study aims to explore the survival benefits of neoadjuvant hepatic arterial infusion chemotherapy (HAIC) for resectable HCC with<bold> </bold>PVTT. <bold>Methods: </bold>This r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e1068578-d030-5af0-86d8-90830490d1f9
DOI
10.21203/rs.3.rs-2170633/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombusDOI 10.21203/rs.3.rs-2170633/v1
Select a neighboring publication to make it the new centre.